- Company Overview for NEUROMIND BIOPHARMA LTD (13342081)
- Filing history for NEUROMIND BIOPHARMA LTD (13342081)
- People for NEUROMIND BIOPHARMA LTD (13342081)
- More for NEUROMIND BIOPHARMA LTD (13342081)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
08 Feb 2024 | AP01 | Appointment of Mr Pierre Coertzen as a director on 1 February 2024 | |
31 Jan 2024 | AA | Total exemption full accounts made up to 30 April 2023 | |
06 Dec 2023 | RP04CS01 | Second filing of Confirmation Statement dated 29 September 2023 | |
29 Sep 2023 | CS01 |
Confirmation statement made on 29 September 2023 with updates
|
|
08 Sep 2023 | AD01 | Registered office address changed from Unit 8 Cibyn Industrial Estate Caernarfon LL55 2BD Wales to Wey Court West Union Road Farnham Surrey GU9 7PT on 8 September 2023 | |
18 Aug 2023 | SH01 |
Statement of capital following an allotment of shares on 12 June 2023
|
|
19 May 2023 | CS01 | Confirmation statement made on 18 April 2023 with updates | |
19 May 2023 | SH01 |
Statement of capital following an allotment of shares on 11 April 2023
|
|
17 May 2023 | SH01 |
Statement of capital following an allotment of shares on 11 April 2023
|
|
09 Jan 2023 | AA | Accounts for a dormant company made up to 30 April 2022 | |
10 Nov 2022 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 4 November 2022
|
|
09 Nov 2022 | SH01 |
Statement of capital following an allotment of shares on 4 November 2022
|
|
10 May 2022 | SH02 | Sub-division of shares on 10 March 2022 | |
22 Apr 2022 | PSC08 | Notification of a person with significant control statement | |
22 Apr 2022 | CS01 | Confirmation statement made on 18 April 2022 with updates | |
22 Apr 2022 | PSC07 | Cessation of Andries Meyer as a person with significant control on 10 March 2022 | |
22 Apr 2022 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 10 March 2022
|
|
22 Mar 2022 | SH01 |
Statement of capital following an allotment of shares on 14 March 2022
|
|
30 Nov 2021 | TM01 | Termination of appointment of Andrew Paul Beggin as a director on 29 November 2021 | |
25 Oct 2021 | AP01 | Appointment of Mr Andrew Paul Beggin as a director on 25 October 2021 | |
18 Oct 2021 | TM01 | Termination of appointment of Andrew Paul Beggin as a director on 4 October 2021 | |
12 Oct 2021 | PSC01 | Notification of Andries Meyer as a person with significant control on 4 October 2021 | |
12 Oct 2021 | PSC07 | Cessation of Andrew Paul Beggin as a person with significant control on 4 October 2021 | |
07 Oct 2021 | AP01 | Appointment of Sir Roger Spencer Jones as a director on 4 October 2021 | |
07 Oct 2021 | AP01 | Appointment of Andreis Meyer as a director on 4 October 2021 |